A Study for Participants With Advanced Cancer

NCT01214629 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancer
Metastatic Cancer

Interventions

DRUG: LY2523355
DRUG: LY2523355
DRUG: pegfilgrastim

Sponsor

Eli Lilly and Company